ORAGENICS, INC. Accounts Payable, Trade, Current
ORAGENICS, INC. (OGEN) had Accounts Payable, Trade, Current of $772.50 thousand as of 2025-03-31, per its 10-Q filed 2025-05-09.
Financial Statements › Notes › Accounts Payable and Accrued Liabilities, Current
us-gaap:AccountsPayableTradeCurrent · last filed 2025-05-09
- 2025-03-31: Accounts Payable, Trade, Current $772.50K.
- 2024-12-31: Accounts Payable, Trade, Current $1.14M.
- 2024-09-30: Accounts Payable, Trade, Current $1.51M.
- 2024-06-30: Accounts Payable, Trade, Current $1.18M.
| Period end | Accounts Payable, Trade, Current | Accounts Payable, Trade, Current as first filed |
|---|---|---|
| 2025-03-31 | $772.50K 10-Q · filed 2025-05-09 | |
| 2024-12-31 | $1.14M 10-Q · filed 2025-05-09 | |
| 2024-09-30 | $1.51M 10-Q · filed 2024-11-13 | |
| 2024-06-30 | $1.18M 10-Q · filed 2024-08-09 | |
| 2024-03-31 | $695.79K 10-Q · filed 2024-05-15 | |
| 2023-12-31 | $1.24M 10-K · filed 2025-03-14 | |
| 2023-09-30 | $808.93K 10-Q · filed 2023-11-09 | |
| 2023-06-30 | $590.58K 10-Q · filed 2023-08-11 | |
| 2023-03-31 | $939.01K 10-Q · filed 2023-05-12 | |
| 2022-12-31 | $246.69K 10-K · filed 2024-03-29 | |
| 2021-12-31 | $854.98K 10-K · filed 2023-04-17 | |
| 2020-12-31 | $330.38K 10-K/A · filed 2022-07-29 | |
| 2019-12-31 | $1.21M 10-K · filed 2021-03-01 | |
| 2018-12-31 | $828.71K 10-K · filed 2020-03-04 | |
| 2017-12-31 | $618.36K 10-K · filed 2019-03-29 | |
| 2016-12-31 | $461.34K 10-K · filed 2018-02-16 | |
| 2015-12-31 | $280.00K 10-K · filed 2017-02-27 | $383.89K 10-K · filed 2016-03-30 |
| 2014-12-31 | $483.64K 10-K · filed 2016-03-30 | |
| 2013-12-31 | $249.23K 10-K · filed 2015-02-27 | |
| 2012-12-31 | $440.38K 10-K · filed 2014-02-28 | |
| 2011-12-31 | $631.27K 10-K · filed 2013-03-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |